GeneTex: Taiwan's Hidden Biotech Champion

撰文GlobalBio & Investment

日期2024-11-28

Prof. Eva Y.H. P. Lee of GeneTex.

A-
A+

加入收藏

For nearly 20 years, GeneTex International Corporation, founded by esteemed Academia Sinica academicians Dr. Wen-Hwa Lee and Prof. Eva Y.H. P. Lee, has quietly built a "biotech TSMC" in Taiwan. With a focus on high-quality antibody production, GeneTex has become a trusted global CDMO leader for antibodies in the biotech industry.

Scientist-founded and science-driven, GeneTex is spearheading research on antibodies targeting G-protein–coupled receptors (GPCRs), offering breakthroughs in clinical diagnostics and therapies to combat diseases.

Discover how GeneTex, the hidden champion of Taiwan’s biotech industry, is shaping the future of precision medicine and global healthcare.

Global Reach & Impact:

Established in 1997, GeneTex operates state-of-the-art facilities in the U.S. and Taiwan.
With 59 global distributors, over 90% of its revenue comes from international markets.

Read more about GeneTex's journey and innovations (written by reporter Wang in Chinese).